Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
How does iron rich food intake impact lipitor's efficacy?Patent term adjustment semaglutida?Patent expiry trametinib?Drug patent watch trametinib?What excipients are combined with ruxolitinib in apotex's medication?
See the DrugPatentWatch profile for dupixent
Dupixent’s Q4 2020 sales were boosted by increases in both the United States and International markets. The company reported that growth came from higher demand across these regions rather than from a single country or territory [1].
Both. The Q4 2020 results highlighted that the year-over-year sales increase reflected contributions from the US as well as International [1].
The available disclosures for Q4 2020 framed the lift at the level of “International” rather than naming specific countries within that segment [1].
[1] https://www.businesswire.com/news/home/20210205005246/en/Regeneron-Reports-Fourth-Quarter-and-Full-Year-2020-Financial-Results
Other Questions About Dupixent :